FUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System
For more information on the TomoTherapy System visit www.accuray.com.
"FUCAM is a large and busy center focused on providing the best possible care to women with breast cancer. We require a radiation therapy system which can keep pace with the demands of our clinic and enable us to deliver precise radiation to any tumor in the shortest amount of time possible," said
The TomoTherapy System is the only radiation system specifically designed for image-guided intensity-modulated radiation therapy (IG-IMRT). Leveraging a CT scanner-based platform, TomoHelical™ mode enables continuous delivery from 360 degrees around the patient with highly conformal and homogeneous dose to the tumor. A clinician can also choose to deliver treatment from specific fixed angles via TomoDirect™ mode. The system's unique architecture helps ensure the highest levels of precision, while minimizing dose to organs at risk. This is especially important for women diagnosed with cancer in the left breast, where the tumor may be close to critical organs such as the heart.
"We are proud of the incredible work FUCAM is pioneering in
FUCAM is a civil partnership with a mission to provide diagnosis and treatment for breast cancer, particularly in the most vulnerable socioeconomic groups, and to promote education about early detection of breast cancer. It´s the first non-profit institution established in
FUCAM developed one of the most important campaigns in
About the TomoTherapy® System
The TomoTherapy® System is capable of treating all standard radiation therapy indications, in addition to complex cases such as total marrow irradiation. Radiation oncologists have treated many types of cancers with the TomoTherapy System, including breast, prostate, lung, head & neck and pediatric. The system efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its innovative design enables treatment plans to be delivered with integrated, daily CT image guidance, enhancing accuracy and delivering highly precise, intensity modulated radiation for optimal sparing of healthy tissue and critical structures.
Potential Radiation Therapy Side Effects
Most side effects of radiotherapy, including radiotherapy delivered with
Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to clinical applications, clinical results, patient outcomes and
Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.
+1 (408) 789-4426
+1 (781) 684-6680
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fucam-treats-1000-breast-cancer-patients-with-the-tomotherapy-system-300287587.html